H.C. Wainwright Reiterates Buy Rating on Intensity Therapeutics, Inc. (INTS)

August 19, 2026 6:46 AM

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $7.00 price target on Intensity Therapeutics, Inc. (NASDAQ: INTS).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found